| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President & CEO
1 company
Luis C. Pena is President & CEO at EVMN. Luis C. Pena's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.7M at current prices.
The EVMN filings lean toward selling, a net 24,225 shares.
Luis C. Pena has 7 Form 4 filings on record from November 2025 to September 2026, all as President & CEO at Evommune (EVMN), 2025–2026.
The 7 reported transactions were 2 open-market sales, 2 option or other derivative awards, 1 stock award and 1 tax withholding, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $551K.
The largest open-market sale was 16,787 shares of EVMN at an average $22.74 on June 1, 2026, about $382K.
Both sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.